(Q33934163)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10838574%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

review article

1 reference

title

Peptides, Pseudomonas aeruginosa, polysaccharides and lipopolysaccharides--players in the predicament of cystic fibrosis patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10838574%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

main subject

cystic fibrosis

0 references

Pseudomonas aeruginosa

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10838574%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Pier GB

series ordinal

1

1 reference

30 July 2017

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10838574%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

published in

Trends in Microbiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10838574%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10838574%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10838574%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

247-50; discussion 250-1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10838574%20AND%20SRC:MED&resulttype=core&format=json

Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2901743-1

7 January 2021

Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2901743-1

7 January 2021

Mediation of the killing of rough, mucoid isolates of Pseudomonas aeruginosa from patients with cystic fibrosis by the alternative pathway of complement

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2901743-1

7 January 2021

Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2901743-1

7 January 2021

Structural studies of lipid A from Pseudomonas aeruginosa PAO1: occurrence of 4-amino-4-deoxyarabinose

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2901743-1

7 January 2021

Characterization of lipid A from Pseudomonas aeruginosa O-antigenic B band lipopolysaccharide by 1D and 2D NMR and mass spectral analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2901743-1

7 January 2021

Studies of lipopolysaccharides from Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2901743-1

7 January 2021

Studies of lipid A fractions from the lipopolysaccharides of Pseudomonas aeruginosa and Pseudomonas alcaligenes

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2901743-1

7 January 2021

Fatty acid alterations and polymyxin B binding by lipopolysaccharides from Pseudomonas aeruginosa adapted to polymyxin B resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2901743-1

7 January 2021

Relationship between chemical composition and biological function of Pseudomonas aeruginosa lipopolysaccharide: effect on human neutrophil chemotaxis and oxidative burst

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2901743-1

7 January 2021

PhoP-PhoQ homologues in Pseudomonas aeruginosa regulate expression of the outer-membrane protein OprH and polymyxin B resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2901743-1

7 January 2021

Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2901743-1

7 January 2021

Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2901743-1

7 January 2021

Activity of abundant antimicrobials of the human airway

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2901743-1

7 January 2021

Production of beta-defensins by human airway epithelia

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2901743-1

7 January 2021

Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2901743-1

7 January 2021

Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2901743-1

7 January 2021

Systematic review of antistaphylococcal antibiotic therapy in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2800%2901743-1

7 January 2021

10.1016/S0966-842X(00)01743-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10838574%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference